Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumab. - Incorvaia L; Scagliarini S; Marques Monteiro FS; Takeshita H; Tapia JC; Gandur Quiroga MN; Lam E; Tural D; Popovic L; Campos-Gomez S; Zucali PA; Mota A; et al. (Scientific reports, 2025)